活性氧
化学
激进的
谷胱甘肽
催化作用
超氧化物
生物物理学
抗氧化剂
铁质
单线态氧
体内
组合化学
生物化学
酶
氧气
有机化学
生物技术
生物
作者
Sijin Xiang,Zhongxiong Fan,Zichen Ye,Tianbao Zhu,Dao Shi,Shefang Ye,Zhenqing Hou,Xiaolan Chen
出处
期刊:Nano Research
[Springer Science+Business Media]
日期:2021-06-25
卷期号:15 (2): 907-918
被引量:36
标识
DOI:10.1007/s12274-021-3574-x
摘要
Chemodynamic therapy (CDT) is well acknowledged as potent reactive oxygen species (ROS)-mediated anticancer strategy. Especially, the study about labile iron pool (LIP) as endogenous ferrous catalyzer has paved the way for future CDT development. However, limited H 2 O 2 expression, mild acidity, reduced glutathione (GSH) ablation of ROS, etc., all require employing alternate peroxo-complex to achieve enhanced CDT effect. As a non-Fenton-type substrate, artesunate (ART) has been utilized as a source of free radicals through decomposition of endoperoxide bridges catalyzed by ferrous ions, nonetheless, the non-tumor-specific delivery, inferior pharmacokinetics, and hydrophobic nature minimize the efficacy of ART in physiological systems. Herein, we devise a PPA nanoamplifier by conjugating ART with PEG-functionalized Pd@Pt nanoplates (PP NPs) to form ester linkage, ensuring specific intratumoral esterase-responsive ART release. Significantly, the PPA nanoamplifier combines the in situ decomposition of ART’s endoperoxide bridges by Fe 2+ to superoxide anions (O 2 ·− ) and peroxidase (POD)-like enzymatic catalysis of endogenous H 2 O 2 by PP to hydroxyl radicals (·OH), thus achieving amplified ROS-mediated tumor therapy. Besides, PPA displays GSH destruction potential, thereby protecting ROS from the cleavage by GSH oxidation. In addition, the strong absorption of PPA in near-infrared (NIR) region also endows PPA with photoacoustic property to realize imaging-guided CDT. In short, by taking advantages of the high enrichment and esterase- responsive drug release at tumor sites, PPA amplified ROS signals via dual pathways, killing tumor cells in vitro and inhibiting tumor growth in vivo , thereby realizing high-efficiency non-Fenton CDT. We believe our novel anti-tumor strategy based on PPA will broaden the future of ROS-mediated tumor-targeted therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI